We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
-4.15%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$1.68B
AUM Growth
+$769M
(+84%)
Cap. Flow
+$831M
Cap. Flow
% of AUM
49.48%
Top 10 Holdings %
Top 10 Hldgs %
8.16%
Holding
2,474
New
799
Increased
624
Reduced
373
Closed
629
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.65M |
| 2 |
NFINU
Netfin Acquisition Corp. Unit
NFINU
|
+$2.57M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$2.42M |
| 4 |
Humana
HUM
|
+$2.37M |
| 5 |
Cigna
CI
|
+$2.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JFKKU
8i Enterprises Acquisition Corp Unit
JFKKU
|
+$1.58M |
| 2 |
GIX.U
GigCapital2, Inc.
GIX.U
|
+$1.35M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$1.31M |
| 4 |
CHAC.U
Chardan Healthcare Acquisition Corp.
CHAC.U
|
+$1.27M |
| 5 |
Artisan Partners
APAM
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.91% |
| 2 | Technology | 1.1% |
| 3 | Consumer Discretionary | 1.05% |
| 4 | Communication Services | 0.58% |
| 5 | Materials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
CALL
Wayfair
W
$11.1B
| $1.63M | 0.1% |
14,500
-2,100
| -13% | -$269K |
|
277
CALL
Teladoc Health
TDOC
$1.58B
| $1.63M | 0.1% |
24,000
+3,600
| +18% | +$237K |
|
278
CALL
Alibaba
BABA
$269B
| $1.62M | 0.1% |
+9,700
| New | +$1.67M |
|
|
AXON
279
CALL
Axon Enterprise
AXON
$40.5B
| $1.61M | 0.1% |
28,400
+16,000
| +129% | +$1.01M |
|
280
CALL
EOG Resources
EOG
$78B
| $1.6M | 0.1% |
+21,600
| New | +$1.75M |
|
|
CYBR
281
PUT
DELISTED
CyberArk
CYBR
| $1.6M | 0.1% |
16,000
+15,400
| +2,567% | +$1.86M |
|
282
CALL
United Therapeutics
UTHR
$26.3B
| $1.59M | 0.1% |
20,000
-900
| -4% | -$72.5K |
|
283
CALL
Take-Two Interactive
TTWO
$43B
| $1.59M | 0.09% |
+12,700
| New | +$1.58M |
|
284
CALL
Ciena
CIEN
$55.3B
| $1.59M | 0.09% |
40,500
+25,100
| +163% | +$1.05M |
|
285
PUT
Ralph Lauren
RL
$22.2B
| $1.58M | 0.09% |
16,600
+14,900
| +876% | +$1.47M |
|
286
CALL
Revvity
RVTY
$12.3B
| $1.58M | 0.09% |
18,600
-1,000
| -5% | -$87.5K |
|
287
PUT
Teva Pharmaceuticals
TEVA
$35.9B
| $1.58M | 0.09% |
230,300
+230,200
| +230,200% | +$1.76M |
|
288
CALL
Zillow
Z
$7.04B
| $1.58M | 0.09% |
53,100
+50,600
| +2,024% | +$2.02M |
|
|
ABMD
289
CALL
DELISTED
Abiomed Inc
ABMD
| $1.58M | 0.09% |
8,900
+1,200
| +16% | +$259K |
|
290
CALL
Repligen
RGEN
$7.44B
| $1.58M | 0.09% |
20,600
-30,500
| -60% | -$2.67M |
|
291
PUT
Thermo Fisher Scientific
TMO
$211B
| $1.57M | 0.09% |
+5,400
| New | +$1.55M |
|
292
CALL
Colgate-Palmolive
CL
$72.6B
| $1.57M | 0.09% |
+21,300
| New | +$1.55M |
|
293
CALL
Accenture
ACN
$89.9B
| $1.56M | 0.09% |
8,100
+3,200
| +65% | +$619K |
|
294
PUT
Oracle
ORCL
$331B
| $1.56M | 0.09% |
28,300
+26,000
| +1,130% | +$1.44M |
|
|
SKX
295
DELISTED
Skechers
SKX
| $1.56M | 0.09% |
+41,677
| New | +$1.43M |
|
296
PUT
Ulta Beauty
ULTA
$20.4B
| $1.55M | 0.09% |
6,200
+5,800
| +1,450% | +$1.78M |
|
|
SCPE.U
297
DELISTED
SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o
SCPE.U
| $1.55M | 0.09% |
+150,000
| New | +$1.54M |
|
298
PUT
Agios Pharmaceuticals
AGIO
$2.16B
| $1.55M | 0.09% |
47,900
+34,600
| +260% | +$1.43M |
|
299
Trade Desk
TTD
$8.13B
| $1.55M | 0.09% |
82,660
+80,260
| +3,344% | +$1.91M |
|
|
BLUE
300
PUT
DELISTED
bluebird bio
BLUE
| $1.54M | 0.09% |
1,297
+1,197
| +1,197% | +$1.83M |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Walleye Capital held 2,474 positions worth $1.68B, up 84% from $910M the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
Walleye Capital deployed $831M of net new capital in Q3 2019, opening 799 new positions and adding to 624 existing holdings. Its largest new stake was Meta Platforms (Facebook): 13,918 shares worth $2.48M.
By sector, the portfolio is most concentrated in Healthcare at 1.9% of assets, up from 1.8% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Arqule Inc, an estimated $1.22M trimmed.
- Walleye Capital's largest Q3 2019 buy was Meta Platforms (Facebook): 13,918 shares worth $2.48M.
- Walleye Capital added most to Abiomed Inc in Q3 2019, an estimated $2.42M increase.
- Walleye Capital's biggest Q3 2019 reduction was Arqule Inc, cutting an estimated $1.22M.
- Walleye Capital fully exited 8i Enterprises Acquisition Corp Unit in Q3 2019, selling an estimated $1.58M.
- Walleye Capital's ten largest holdings make up 8.2% of its $1.68B portfolio in Q3 2019.
- Walleye Capital opened 799 new positions and closed 629 in Q3 2019.
- Walleye Capital's portfolio value rose 84% quarter-over-quarter to $1.68B.
Based on Walleye Capital's 13F filing for Q3 2019, filed 14 Nov 2019.